Innovation to Impact: Drug Development, AI, and Regulatory Strategy
Patients First. Platforms Second
· 36 perc · 1. évad 1. epizód
Epizódjegyzetek
Click here to watch a video of this episode.
In drug development, translational science can generate endless options, but decision-grade evidence starts with the patient decision. This episode looks at why AI and digital biomarkers often get adopted before we agree what “better” means for patients and for the teams who carry the risk. Here’s the uncomfortable question: are we improving outcomes, or just improving the story we tell ourselves about progress? We talk about how platform-first thinking quietly rewires priorities, shifts incentives, and turns “innovation” into a procurement cycle…
Weboldal: share.transistor.fm
